'maraviroc' can also refer to...


maraviroc n.

Pharmacokinetics of the raltegravir/maraviroc/etravirine combination

Maraviroc: integration of a new antiretroviral drug class into clinical practice

Virological failure of patients on maraviroc-based antiretroviral therapy

Maraviroc: The First of a New Class of Antiretroviral Agents

Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients

In vitro effects of the CCR5 inhibitor maraviroc on human T cell function

Maraviroc reduces Regulatory T cells in ART-naïve HIV-infected subjects

Immune recovery and T cell subset analysis during effective treatment with maraviroc

Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients

A Validated Stability-Indicating UPLC Method for the Determination of Impurities in Maraviroc

Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques

Long-term maraviroc use as salvage therapy in HIV-2 infection

Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients

Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy

Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor

Pharmacokinetic interaction of maraviroc with tacrolimus in a patient coinfected with HIV and hepatitis B virus following hepatic transplant due to hepatocellular carcinoma

Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy


More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics


Show Summary Details

Quick Reference

n. an antiretroviral (ARV) drug used, in combination with other ARVs, for treating refractory HIV infection. It acts by binding to and antagonizing CCR5, a receptor for a class of chemokines on the host cell needed by some HIV viruses to enter the cell. It is administered orally; side-effects include gastrointestinal upsets, cough, and dizziness. Trade name: Celsentri.

Subjects: Clinical Pharmacology and Therapeutics.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.